Newly Diagnosed Tumors: Our ApproachMay 8th, 2012 | Posted by in Clinical Trials
Each patient is evaluated to determine whether they can benefit from one of our current clinical trials. We welcome and will evaluate all patients, even if they’ve been evaluated or treated by other physicians or institutions.
If you have already undergone a biopsy, we recommend that you send us your tissue samples for tissue microarray analysis to determine effectiveness of the chemotherapy regimens. This new and innovative part of our program can offer better insights into treatments.
Clinical Trials for Newly Diagnosed Tumors
- Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)